TickerFacts.

NewcelX Ltd. (NCEL): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$55.0K
Year ended 2025-12-31
$620.0K2023-12-31: $620.0K2024-12-31: $413.0K2025-12-31: $55.0K$55.0K
2023-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$55.0K-86.7%2026-04-29, From 2025-01-01
2024-12-31$413.0K-33.4%2026-04-29, From 2024-01-01
2023-12-31$620.0Kn/a2026-04-29, From 2023-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
NewcelX Ltd. (NCEL)2025-12-31$55.0K-86.7%
Decoy Therapeutics Inc. (DCOY)2025-12-31$7.2K+61.6%
Lantern Pharma Inc. (LTRN)2025-12-31$17.3K0.0%
Turn Therapeutics Inc. (TTRX)2025-12-31$52.7K+11.1%
Imunon, Inc. (IMNN)2024-12-31$240.0K-3.2%
Traws Pharma, Inc. (TRAW)2025-12-31$61.0K+408.3%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)2025-12-31$290.1Kn/m
Longeveron Inc. (LGVN)2025-12-31$800.0K+14.3%
PMGC Holdings Inc. (ELAB)2025-12-31$96.1Kn/m

Compare NCEL, DCOY, LTRN, TTRX side by side · Screen every company in Pharmaceutical Preparations ↗